Harima to open myrcene plant
Japanese firm Harima has built its first myrcene facility at its site in Kakogawa. Myrcene is obtained from pinene, a natural substance extracted from pine trees, and used in aroma oils and fragrances. The facility will mainly use energy self-generated from renewable energy sources and carbon-neutral fuel.
The company has long been involved in the manufacture of products developed using rosin, turpentine and tall oil from pine trees. It said that the new plant meets the demand for more sustainable, plant-based resources in flavours and fragrances and enhanced traceability and protection of human rights throughout the supply chain.
RELATED ARTICLES
UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.
Swiss CDMO Siegfried has inaugurated its new global R&D centre for drug substances at its site in Evionnaz.
International Chemical Investors Group (ICIG), the owner of WeylChem and many other European chemical assets, has acquired the European Advanced Organics business of Valtris Specialty Chemicals.
SOCMA, the trade association of the US speciality chemical manufacturing industry, has published an open letter to the pending Trump administration, urging it to “prioritise policies that encourage advancement, streamline regulatory processes and incentivise domestic manufacturing”.
BASF has formed a partnership with Slovenian white biotech Acies Bio. Under this it will further develop the latter’s OneCarbonBio fermentation platform to derive methanol for the production of fatty alcohols for home and personal care ingredients, notably surfactants.
Peptides CDMO AmbioPharm, has broken ground on a 650 m2, $28 million expansion project at its Shanghai manufacturing site. This is due to be complete in 2H 2025 and will produce over 8 tonnes/year of crude peptide.
